Mannatech, Incorporated (NASDAQ:MTEX) Director Sells $126,232.00 in Stock

Mannatech, Incorporated (NASDAQ:MTEXGet Free Report) Director Larry A. Jobe sold 16,288 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the transaction, the director now directly owns 54,721 shares of the company’s stock, valued at $424,087.75. The sale was disclosed in a filing with the SEC, which is available through this link.

Mannatech Price Performance

Shares of NASDAQ:MTEX opened at $7.63 on Wednesday. Mannatech, Incorporated has a one year low of $6.75 and a one year high of $12.75. The stock has a fifty day moving average of $7.26 and a 200-day moving average of $7.79. The company has a market capitalization of $14.34 million, a PE ratio of -8.57 and a beta of 1.17. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.62 and a current ratio of 1.17.

Mannatech (NASDAQ:MTEXGet Free Report) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) EPS for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%. The company had revenue of $27.74 million for the quarter.

Wall Street Analysts Forecast Growth

Separately, StockNews.com initiated coverage on Mannatech in a research report on Saturday. They issued a “buy” rating for the company.

View Our Latest Report on MTEX

Mannatech Company Profile

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Featured Stories

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.